Document:

Executive Change of Control Plan

 Exhibit 10.16 
 IPC The Hospitalist Company 
 EXECUTIVE CHANGE IN CONTROL PLAN 
 The purpose of this IPC The Hospitalist Company Executive Change in Control Plan (the “Plan”) is to secure the continued services of certain
senior executives of IPC The Hospitalist Company and to ensure their continued dedication to their duties in the event of any threat or occurrence of a Change in Control of the Company. The Plan was approved by the Board of Directors on
January 10, 2008, effective contingent upon the consummation of an initial public offering of the Shares of Common Stock of the Company. The Plan is effective on the date that such initial public offering is consummated (the “Effective
Date”). 
 ARTICLE I 
 DEFINITIONS 
 Section 1.1 Definitions 
 Whenever used in this Plan, the following capitalized terms shall have the meanings set forth in this Section 1.1. Certain other capitalized terms
are defined elsewhere in this Plan. 
 (a) “Annual Target Bonus Amount” means the annual target bonus for each
Participant, if any, as set by the Compensation Committee in accordance with the Company’s annual bonus plan or policy for the calendar year in which the Participant incurs a termination of employment. 
 (b) “Base Salary” means (i) for a Participant who has an individual employment agreement with the Company, the annual base
salary as specified in such employment agreement as in effect during the calendar year in which the Participant incurs a termination of employment (including any increases approved by the Compensation Committee), or (ii) for a Participant who
does not have an individual employment agreement with the Company, the base salary shall equal the product of (x) the monthly salary as in effect during the last full month prior to the month in which the Participant incurs a termination of
employment multiplied by (y) twelve (12). 
 (c) “Board” means the Board of Directors of the Company.

 (d) “Cash Severance Payment” means the cash payment of severance compensation as provided in Section 4.2.

 (e) “Cause” means: 
 (i) the willful and continued failure by a Participant to substantially perform his or her duties for the Company (other than any such failure resulting from his or her incapacity due to physical or mental illness or
any such failure subsequent to the delivery of a notice of the Company’s intent to terminate the Participant’s employment without Cause or subsequent to the expiration of the Company’s remedy period following the Participant’s
delivery to the Company of 

 
a notice of his or her intent to terminate employment for Good Reason), and such willful and continued failure continues after a demand for substantial
performance is delivered to the Participant by the Company which specifically identifies the manner in which the Participant has not substantially performed his or her duties; or 
 (ii) the willful engaging by the Participant in illegal conduct or gross misconduct which is injurious to the business or reputation of
the Company. 
 For purposes of determining whether “Cause” exists, no act or failure to act on the part of the Participant shall be
considered “willful” unless done, or omitted to be done, in bad faith and without reasonable belief that the action or omission was in, or not opposed to, the best interests of the Company. Any act, or failure to act, based upon authority
given pursuant to a resolution duly adopted by the Board, based upon the advice of counsel for the Company or upon the instructions to a Participant by a more senior officer of the Company shall be conclusively presumed to be done, or omitted to be
done, in good faith and in the best interests of the Company. Cause shall not exist unless and until the Company has delivered to the Participant a copy of a resolution duly adopted by two-thirds (2/3) of the entire Board (excluding the
Participant if applicable) at a meeting of the Board called and held for such purpose (after reasonable notice to the Participant and an opportunity for the Participant, together with counsel, to be heard before the Board), finding that in the good
faith opinion of the Board an event set forth in clause (i) or (ii) has occurred and specifying the particulars thereof in detail. The Company must notify the Participant of any event constituting Cause within ninety (90) days
following the Company’s knowledge of its existence or such event shall not constitute Cause under this Plan. Notwithstanding the foregoing, with respect to a Participant who has entered into an employment agreement with the Company,
“Cause” shall have the meaning specified in such agreement. 
 (f) “Change in Control” means (a) the
acquisition by any Person of voting Shares which result in such Person being the beneficial owner (within the meaning of Rule 13d-3 under the Exchange Act) of more than fifty percent (50%) of the outstanding voting Shares; provided,
however, a Change in Control shall not be deemed to occur solely because more than fifty percent (50%) of the outstanding voting Shares is beneficially owned by (i) a trustee or other fiduciary holding securities under one or more
employee benefit plans maintained by the Company or any of its subsidiaries, or (ii) any Person which, immediately prior to such acquisition, is owned directly or indirectly by the stockholders of the Company in approximately the same
proportion as their ownership of voting Shares immediately prior to such acquisition; (b) a merger, consolidation or other reorganization involving the Company if the stockholders of the Company and their affiliates, immediately before such
merger, consolidation or other reorganization, do not, as a result of such merger, consolidation, or other reorganization, own directly or indirectly, more than fifty percent (50%) of the combined voting power of the then outstanding voting
shares of the entity resulting from such merger, consolidation or other reorganization; (c) a complete liquidation or dissolution of the Company; or (d) the sale or other disposition of all or substantially all of the assets of the Company
and its subsidiaries determined on a consolidated basis. 

 (g) “Change in Control Period” means the period described in Section 9.7
hereunder. 
 (h) “Code” means the Internal Revenue Code of 1986, as amended. 
 (i) “Committee” means the committee appointed by the Chief Executive Officer of the Company to administer the Plan pursuant to
Section 8.1. 
 (j) “Common Stock” means common stock, par value $.001 per share, of the Company. 

(k) “Company” means IPC The Hospitalist Company, a Delaware corporation, any successor or assignee as provided in Article VI
and any Subsidiary, as applicable. 
 (l) “Compensation” means a Participant’s Base Salary plus Annual
Target Bonus Amount for the year in which the termination of employment occurs (determined without regard to any diminution in such Base Salary or Annual Target Bonus Amount that constitutes Good Reason for Participant’s resignation or would
constitute such Good Reason but for the fact that it is less than the specified materiality threshold ($20,000)). Notwithstanding anything herein to the contrary, “Compensation” shall not include a Participant’s income from the
grant or vesting of restricted stock, or from the grant, vesting, or exercise of stock options, or any other awards under any of the Company’s equity incentive plans. 
 (m) “Compensation Committee” means the compensation committee of the Board. 
 (n) “Disability” means a Participant’s inability to engage in any substantial gainful activity by reason of any medically
determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months, as determined by the Committee. Notwithstanding the foregoing, with
respect to a Participant who has entered into an employment agreement with the Company, “Disability” shall have the meaning specified in such agreement as “Disability” or “Permanent Disability.” 
 (o) “Eligible Employee” means a regular full-time salaried employee of the Company who is a member of a select group of
management or highly compensated employees of the Company. 
 (p) “Employee Grade” means the grade to which a
Participant is designated in accordance with Section 3.1 or assigned by the Compensation Committee in accordance with Section 3.2. 
 (q) “ERISA” means the Employee Retirement Income Security Act of 1974, as amended. 
 (r) “Exchange Act” means the Securities Exchange Act of 1934, as amended. 

 (s) “Good Reason” means the occurrence, without a Participant’s express
written consent, of any of the following events, provided that the Participant shall have given the Company written notice that circumstances that Employee believes potentially constitute one of the following Good Reason events exist no later than
ninety (90) days after the date that such circumstances come into existence, with specific explanation of the circumstances and the provision of this definition under which Good Reason has arisen: 
 (i) a reduction by the Company of a Participant’s Base Salary and Annual Target Bonus Amount (if any) as in effect immediately before
a Change in Control which represents or will represent, in any 12-month period following such reduction, a reduction of $20,000 in either Base Salary, target Annual Bonus, or the aggregate of Base Salary and target Annual Bonus; 
 (ii)(A) any material and adverse change in a Participant’s authority, duties and responsibilities as in effect immediately before the
Change in Control, or a material and adverse change, after the occurrence of a Change in Control, in the duties, responsibilities, authority or the managerial level of the individual or body of individuals to whom a Participant reports;
provided, however, that Good Reason shall not be deemed to occur upon a change in duties or responsibilities (other than reporting responsibilities) that is solely and directly a result of the Company no longer being a publicly traded
entity and does not involve any other event set forth in this paragraph (ii), or (B) a material and adverse change in a Participant’s titles or offices (excluding, if applicable, membership on the Board) with the Company as in effect
immediately prior to a Change in Control; 
 (iii) the Company’s requiring a Participant to be based more than fifty
(50) miles from the location of such Participant’s place of employment immediately before a Change in Control, except for normal business travel in connection with the Participant’s duties with the Company; or 
 (iv) the failure of the Company to obtain the assumption agreement from any successor as contemplated in Article VI hereof. 
 Good Reason shall not exist unless, following receipt by the Company of the Participant’s notice under this Section 1.1(s), the Company is
provided with thirty (30) days to remedy the circumstances that would constitute Good Reason. After receipt, a Participant’s continued employment shall not, subject to the requirements under this Section 1.1(s), constitute consent to,
or a waiver of rights with respect to, any event or condition constituting Good Reason; provided that any termination of a Participant’s employment for Good Reason as a result of such event or condition must occur no later than the second
anniversary of the date that such condition initially arose. At any time after such notice has been given and Good Reason exists (and has not been cured), a termination of Employee’s employment due to Disability shall be deemed a termination by
the Company not for Cause and not a termination due to Disability. Notwithstanding the foregoing, with respect to a Participant who has entered into an employment agreement with the Company, “Good Reason” shall have the meaning specified
in such agreement. 

 (t) “Multiplier” for each Employee Grade shall be the number set forth opposite
such Employee Grade below: 
  

			
	 Employee Grade
	  	Multiplier
	 Grade One
	  	1.5
	 Grade Two
	  	1.0

 (u) “Participant” means an Eligible Employee designated (i) as of
the Effective Date, in Section 3.1 as a participant in the Plan or (ii) after the Effective Date, by the Compensation Committee to participate in the Plan pursuant to Section 3.2; provided, however, that with respect to
an Eligible Employee who has not entered into an employment agreement with the Company, such Eligible Employee shall not become a Participant eligible to receive any benefits under the Plan until the Employee has executed a copy of, and delivered to
the Company, the Restrictive Covenant Agreement attached as Exhibit “A”. 
 (v) “Person” means any
individual, sole proprietorship, corporation, partnership, joint venture, limited liability company, association, joint-stock company, trust, unincorporated organization, institution, public benefit corporation, entity or government instrumentality,
division, agency, body or department. 
 (w) “Release” means, (i) with respect to a Participant who has entered
into an employment agreement with the Company that has a release attached as an exhibit to such employment agreement, such release, or (ii) with respect to a Participant who has not entered into an employment agreement with the Company or who
has entered into an employment agreement that does not have a release attached as an exhibit, a release acceptable to the Company and in a form substantially similar to the Separation and General Release Agreement attached hereto as Exhibit
“B”. 
 (x) “Separation from Service” means a Participant’s termination of employment from the
Company which constitutes a “separation from service,” as such term is defined under Section 409A of the Code or applicable guidance or regulations thereunder, including Treasury Regulation § 1.409A-1(h). References to
“termination of employment” hereunder mean Participant’s Separation from Service and shall be interpreted in a way consistent with Treasury Regulation § 1.409A-1(h) and other applicable guidance under Section 409A.

 (y) “Severance Benefit” means the Cash Severance Payment and all other payments and benefits as provided in
Articles II and IV. 

 (z) “Severance Period” for each Employee Grade shall be the number set forth
opposite such Employee Grade below: 
  

			
	 Employee Grade
	  	 Severance
 Period

	 Grade One
	  	18 Months
	 Grade Two
	  	12 Months

 (aa) “Share” means a share of the Common Stock. 
 (bb) “Subsidiary” means any corporation or other Person, a majority of the voting power, equity securities or equity interest of
which is owned directly or indirectly by the Company. 
 ARTICLE II 
 INDEMNIFICATION AND GROSS-UP FOR EXCISE TAXES 
 Section 2.1
Gross-Up 
 (a) In the event that a Participant shall become entitled to amounts pursuant to Article IV hereof or
other payments or benefits from the Company under this agreement or any other agreement, plan or arrangement (collectively, the “Company Payments”), and such Company Payments will be subject to the tax imposed by Section 4999 of the
Code or any similar provision of state or local income tax law (the “Excise Tax”), the Company shall pay to such Participant at the time specified in Section 2.1(c) below, an additional amount (the “Gross-Up Payment”) such
that the net amount retained by the Participant, after deduction of any Excise Tax on the Company Payments and the Excise Tax and any other federal, state and local income or payroll tax on the Gross-Up Payment provided hereby, but before deduction
for any federal, state, and local income or payroll tax on the Company Payments, shall be equal to the Company Payments. Notwithstanding the foregoing provisions of this Section 2.1(a) to the contrary, if it shall be determined that the
Participant is entitled to a Gross-Up Payment, but the Company Payments do not exceed one hundred ten percent (110%) of the greatest amount that could be paid to the Participant without the Company Payments giving rise to any Excise Tax (the
“Reduced Amount”), then no Gross-Up Payment shall be made to the Participant and the Company Payments, in the aggregate, shall be reduced to the Reduced Amount (with the payments to be first reduced being the portion of the Severance
Payments that constitute deferrals of compensation under Section 409A followed next by other Severance Payments).. Notwithstanding the foregoing provisions of this Section 2.1(a) to the contrary, the Gross-Up Payment shall not exceed two
times the amount of Employee’s Base Salary in effect at the time of the Change in Control or at the time of termination of employment (whichever is higher). 
 (b) To the extent a Participant is eligible to receive a Gross-Up Payment pursuant to this Article II, the Company shall provide such
Participant with a written statement (the “Statement”) showing the computation of such Gross-Up Payment and the Excise Tax to which it relates, and setting forth the determination of the amount of gross income the Participant is required
to recognize as a result of such payments and the Participant’s liability for the Excise Tax. All computations and determinations required to be made under this Article II, including whether and when a Gross-Up Payment is required, the amount
of such Gross-Up Payment and the assumptions to be utilized in 

 
arriving at such computations and determinations, shall be made by the public accounting firm that is retained by the Company as of the date immediately
prior to the Change in Control (the “Accounting Firm”), which shall provide detailed supporting calculations both to the Company and the Participant within fifteen (15) business days of the receipt of notice from the Company or the
Participant that there has been a Company Payment, or such earlier time as is requested by the Company (the “Determination”). For purposes of the Determination, the Participant shall be deemed to (i) pay federal income taxes at the
highest marginal rates of federal income taxation for the calendar year in which the Gross-Up Payment is to be made, and (ii) pay applicable state and local income taxes at the highest marginal rate of taxation for the calendar year in which
the Gross-Up Payment is to be made, net of the maximum reduction in federal income taxes which could be obtained from deduction of such state and local taxes. 
 (c) The Company shall pay the Gross-Up Payment to the Participant within thirty (30) days following receipt of the Statement;
provided, however, that any such Gross-Up Payment shall not be made later than the last day of the calendar year following the year in which the Participant remits the Excise Tax to the relevant tax authority. 
 (d) The Participant shall cause his or her federal, state and local income tax returns for the period in which such Participant receives
such Gross-Up Payment to be prepared and filed in accordance with the Statement, and, upon such filing, the Participant shall certify in writing to the Company that such returns have been so prepared and filed. At the Participant’s request, the
Company shall furnish to the Participant, at no cost, assistance in preparing his or her federal, state and local income tax returns for the period in which the Participant receives such Gross-Up Payment in accordance with such statement.
Notwithstanding the provisions of Section 2.1(a), the Company shall not be obligated to indemnify the Participant from and against any tax liability, cost or expenses (including, without limitation, any liability for the Excise Tax or
attorney’s fees or costs) to the extent such tax liability, cost or expense is attributable to the Participant’s failure to comply with the provisions of this Section 2.1(d). 
 (e) The costs for the Accounting Firm’s actions taken pursuant to this Article II shall be borne one hundred percent (100%) by
the Company. 
 ARTICLE III 
 ELIGIBILITY 
 Section 3.1 Named Participants 
 The following Eligible Employees are hereby designated as Participants at the applicable Employee Grade as listed below: 
  

			
	 Participant
	  	Employee Grade
	 Adam Singer
	  	One
	 R. Jeffrey Taylor
	  	Two
	 Devra Shapiro
	  	Two
	 Richard Russell
	  	Two

 Section 3.2 Appointed Participants 
 In addition to the Participants named in Section 3.1, the Compensation Committee shall have the authority to designate an Eligible Employee as a
Participant, and to designate such matters as the date that participation by the Eligible Employee shall commence and the appropriate Employee Grade, in each case at its sole discretion. 
 ARTICLE IV 
 SEVERANCE BENEFITS 
 Section 4.1 Right to Severance Benefit; Release 
 Subject to the execution and delivery by the Participant of the Release, and to such Release becoming effective, the Participant shall be eligible to receive (i) a Cash Severance Payment from the Company in the
amount provided in Section 4.2 at such time as provided in Section 4.4, and (ii) such other benefits and rights provided in Article II and Sections 4.5, 4.6 and 4.8, in each case provided that the Participant incurs a termination of
employment from the Company within ninety (90) days immediately preceding or eighteen (18) months immediately following the occurrence of a Change in Control for any reason other than: 
 (a) Death, 
 (b) Disability, 
 (c) Termination by the Company for Cause, 
 (d) Voluntary termination by the Participant for other than Good Reason, or 
 (e) A corporate transaction by the Company selling the Subsidiary which employed the Participant before such transaction, but only if such
Participant is offered employment with the purchaser of such Subsidiary on substantially the same terms and conditions under which such Participant worked for such subsidiary before the transaction. 
 Section 4.2 Amount of Cash Severance Payment 
 The amount of the Cash Severance Payment shall equal the product of the Participant’s Compensation multiplied by the Multiplier for the Participant’s Employee Grade, less applicable withholdings. 

Section 4.3 Offset for Payments Under Employment Agreement or Other Arrangement with Company; No Mitigation. 
 Notwithstanding anything herein to the contrary, any Severance Benefit payable or benefit provided to a Participant hereunder shall be reduced by the
amount of severance payments and comparable benefits to which the Participant is entitled under any plan or program 

 
sponsored by the Company or under any similar arrangement entered into by the Company and the Participant, including, but not limited to, employment
agreements; provided, however, that a payment or benefit under such other plan or program or arrangement that is not of a type provided hereunder shall not result in a reduction of the Severance Benefit payable or benefit provided hereunder. The
nature of a payment or benefit as “comparable” shall be determined without regard to provisions specifying that payments are deemed to be “separate” payments for purposes of Section 409A. The Company acknowledges and agrees
that the Participant shall be entitled to receive all amounts due pursuant to this Article IV regardless of any income which the Participant may receive from other sources following termination of employment from the Company 
 Section 4.4 Payment of Severance Benefit 
 The Participant’s ability to receive the Severance Benefit is contingent upon (i) the Participant executing, timely delivering to the Company and not revoking the Release provided to the Participant
by the Company and (ii) the Participant’s compliance with the restrictive covenants set forth in the employment agreement or any other agreement entered into by the Participant and the Company, including, but not limited to, the
Restrictive Covenant Agreement attached as Exhibit “A”; provided, that, if a Participant breaches any such restrictive covenant, then, in addition to other available remedies provided in such agreement or under
applicable law, such Participant shall cease to be eligible for any Severance Benefit or other benefits under this Plan, and, upon the Company’s written request, must promptly repay to the Company any Severance Benefit and monetary value of
other benefits previously received under the Plan; provided further that, subject to Section 4.7, any amount to be repaid shall be on a gross basis, without reduction for any taxes incurred. Provided that the Participant
meets these conditions, the Cash Severance Payment shall be paid to the Participant, in monthly cash payments, for the duration of the applicable Severance Period, with each applicable monthly payment equal to the Cash Severance Payment divided by
the number of months in the applicable Severance Period. 
 Section 4.5 Medical and Dental Benefits Continuation 

 Any Participant who is entitled to the Cash Severance Payment hereunder, shall, for the duration of the applicable Severance Period
following his or her termination of employment with the Company, be eligible to continue coverage in the medical and dental plans maintained by the Company during such period on the same terms and conditions as if the Participant remained an active
employee of the Company during such Severance Period. The coverage required by this Section 4.5 need only be provided by the Company if the Participant (on behalf of himself or herself and his or her eligible dependents) makes the appropriate
election as required by Section 4980B of the Code and otherwise complies with the requirements of Section 4980B of the Code. 
 Section 4.6 Withholding of Taxes 
 The Company shall withhold from any amounts or benefits payable to the
Participant under this Plan all federal, state, local, city, employment or other taxes required by applicable law to be withheld by the Company. 

 Section 4.7 Rules for Compliance with Code Section 409A. This Section 4.7
serves to ensure compliance with applicable requirements of Section 409A. Certain provisions of this Section 4.7 modify other provisions of this Plan. If the terms of this Section 4.7 conflict with other terms of the Plan, the terms
of this Section 4.7 control. Before January 1, 2009, the timing of payments and distributions under the Plan and other terms relating to Section 409A compliance may be varied to the extent permitted under applicable Section 409A
transition rules and in good faith compliance with Section 409A and IRS Notice 2005-1 and other applicable guidance under Section 409A. 
 (a) Severance Under Other Plans or Agreements; Separate Payments. If a Participant has an employment agreement or otherwise is entitled to severance payments upon a termination that also would result in a Severance Benefit under this
Plan (“Non-Plan Severance”), the amount of such Non-Plan Severance actually payable or that would have been payable if your termination were not otherwise subject to this Plan shall be calculated at the time of your termination. Each
installment payment that actually comprises or that would have comprised the Non-Plan Severance shall be deemed a separate payment for purposes of Section 409A (and portions of each installment shall be deemed separate payments as provided
under the terms of such Non-Plan Severance). If such Non-Plan Severance in fact is payable, or is replaced by the Severance Benefit, payments thereof shall be paid in accordance with the timing rules and other provisions of the agreement, plan or
arrangement under which the Non-Plan Severance is or was to be paid. If such Non-Plan Severance is deemed to be replaced by the Severance Benefit, the portion of the Severance Benefit that exceeds the Non-Plan Severance, including the part
attributable to a higher severance multiplier and the part attributable to including annual bonus in the formula for calculating the Severance Benefit as compared to such Non-Plan Severance, each will be deemed to be a separate payment for purposes
of Section 409A. 
 (b) Separate Payments Comprising the Severance Benefit. To the extent that payments of the Severance Benefit
are deemed separate from Non-Plan Severance, payments of the Severance Benefit shall further be deemed to be separate payments for purposes of Section 409A as follows: 
  

	 	(i)	 Each monthly installment payable in the first three months following termination of employment shall be a separate payment, payable, to the maximum extent
permissible, under the short-term deferral rule set forth in Treasury Regulation § 1.409A-1(b)(4). If the monthly installment payable in the third month following termination would be payable in March, such installment shall be paid no later
than March 15. The first two of these monthly installments shall not be paid until the date after Participant has executed the Release required under Section 4.4 and may no longer revoke such Release (this date varies but in no event is
later than 52 days after termination of employment). If these payments are not payable under as a short-term deferral, they shall be payable instead under the “two-years/two-times” exclusion from Section 409A under Treasury Regulation
§ 1.409A-1(b)(9)(iii), up to the applicable limits of that exclusion (after applying the exclusion under Section 4.7(a) or under any other plan or arrangement to which it may be applicable). To the extent these payments do not qualify as
short-term deferrals or under the “two-year/two-times” exception, such amounts 

	 	 
shall be deemed to be deferred compensation under Section 409A and shall be subject to the six-month delay rule set forth in Section 4.7(c), if
applicable. 

  

	 	(ii)	Each month’s installment payable in the fourth, fifth and sixth months following Participant’s termination of employment shall be a separate payment payable, to the
maximum extent permissible, under the “two-years/two-times” exclusion from Section 409A under Treasury Regulation § 1.409A-1(b)(9)(iii), up to the applicable limits of that exclusion (after applying the exclusion under Sections
4.7(a) and 4.7(b)(i) and any other plan or arrangement to which it may be applicable). To the extent these payments do not qualify under the “two-year/two-times” exception, such amounts shall be deemed to be deferred compensation under
Section 409A and shall be subject to the six-month delay rule set forth in Section 4.7(c), if applicable. 

  

	 	 (iii)
	 Each month’s installment payable from the seventh through the 18th
 month following Participant’s termination of employment shall be deemed to include two separate payments, one of which is a payment equal to one-twelfth of the amount of the
“two-years/two-times” exclusion under Treasury Regulation § 1.409A-1(b)(9)(iii) not applicable to payments prior to the seventh month after termination under the rules set forth above and after applying the exclusion under any other
plan or arrangement to which it may be applicable (the “Excluded Portion”), and the other separate payment for each month being the remaining amount of such Severance Payment, if any (i.e., the total monthly Severance Payment minus the
Excluded Portion), shall be deemed to be deferred compensation subject to Section 409A and shall be subject to the six-month delay rule set forth in Section 4.7(c), if applicable. 

 (c) Six-Month Delay Rule. 
  

	 	(i)	The six-month delay rule will apply to certain payments and benefits under the Plan if all of the following conditions are met: 

  

	 	(A)	Participant is a “key employee” (as defined in Code Section 416(i) without regard to paragraph (5) thereof) for the year in which the Termination occurs. The
Company will determine status of “key employees” annually, under administrative procedures applicable to all Section 409A plans and arrangements and applied in accordance with Treasury Regulation § 1.409A-1(i).

  

	 	(B)	The Company’s stock is publicly traded on an established securities market or otherwise. 

  

	 	(C)	The payment or benefit in question is a deferral of compensation and not excepted, exempted or excluded from being such by the short-term deferral rule, or the
“two-years/two-times” rule in Treasury Regulation § 1.409A-1(b)(9)(iii), or any other exception, exemption or exclusion; provided, however, that the exclusion under Treasury Regulation § 1.409A-1(b)(9)(v)(D)

	 	 
shall apply only if and to the extent that it is not necessary to apply to any other payment or benefit payable within six months after the
Participant’s Termination. 

  

	 	(ii)	Effect of Rule. If it applies, the six-month delay rule will delay a payment or benefit which otherwise would be payable under this Plan within six months after
Participant’s Separation from Service. 

  

	 	(A)	Any delayed payment or benefit shall be paid on the date six months after Participant’s Separation from Service. 

  

	 	(B)	During the six-month delay period, accelerated payment will occur in the event of the Participant’s death but not for any other reason (including no acceleration upon a Change
in Control), except for accelerations expressly permitted under Treasury Regulation § 1.409A-1–A-6. 

  

	 	(C)	Any payment that is not triggered by a termination of employment, or is triggered by a termination but would be made more than six months after the Termination (without applying
this six-month delay rule), or is triggered by Participant’s death shall be unaffected by the six-month delay rule. 

  

	 	(iii)	Limit to Application of Six-Month Delay Rule. If the terms of this Plan or other plan or arrangement or document relating to this Plan or payments hereunder impose this
six-month delay rule in circumstances in which it is not required for compliance with Section 409A, those terms shall not be given effect. 

 (d) Certain Benefits. With respect to benefits provided following Participant’s termination of employment, the provision of each such benefit (whether provided in kind by the Company, provided by third
parties but to be paid for by the Company, or reimbursed to Participant by the Company) in each calendar year shall be deemed a separate payment by the Company, and each component separately covered by clauses (i) – (v) below shall be
deemed a separate payment. The following payment rules apply to ensure, to the greatest extent possible. that provision of these benefits does not result in Section 409A penalties to Participant: 
  

	 	(i)	Payments that are non-taxable to Participant are intended to be not subject to Section 409A. 

  

	 	(ii)	Certain payments, including but not limited to business expense reimbursements, are excluded from being deemed deferrals of compensation under Treasury Regulation §
1.409A-1(b)(9)(v)(A), (B) and (C); such payments may be incurred or provided during the period from termination of employment until the last day of Participant’s second taxable year following the taxable year of Participant’s
Termination, provided that reimbursements must be paid no later than the Participant’s third taxable year following the year of Participant’s Termination (or any greater or lesser period applicable to medical expenses under Treasury
Regulation § 1.409A-1(b)(9)(v)(B)). 

	 	(iii)	Payments shall be excluded under other applicable provisions of Treasury Regulation § 1.409A-1–A-6 (including Treasury Regulation § 1.409A-1(b)(4) and
(10)–(12)). 

  

	 	(iv)	Any such payments not covered under the foregoing rules shall be payable to the greatest extent permissible as a reimbursement to Participant or as an in-kind benefit to Participant
meeting the requirements of Treasury Regulation § 1.409A-3(i)(1)(iv). For this purpose, the amount of any such payment in any one of Participant’s taxable years shall not affect the eligible amount of a related payment in any other of
Participant’s taxable years (excluding medical expenses to the extent provided in Treasury Regulation § 1.409A-3(i)(1)((iv)(B)), and any payment in reimbursement of an eligible expense shall be made no later than the last day of
Participant’s taxable year following the taxable year in which the expense was incurred. A payment subject to this clause (iv) may not be subject to liquidation or exchange for another benefit. 

  

	 	(v)	Any payment not excluded from being a deferral of compensation and not otherwise covered by clauses (i) – (iv) above shall nevertheless be payable as a separate
payment under this Plan. 

 (e) Other Provisions. 
  

	 	(i)	No Influence on Year of Payment. In the case of any payment under the Plan payable during a specified period of time following a termination of employment or other event, if
such permitted payment period begins in one calendar year and ends in a subsequent calendar year, Participant shall have no right to elect in which year the payment will be made, and the Company’s determination of when to make the payment shall
not be influenced in any way by Participant. 

  

	 	(ii)	Good Reason. The definition of “Good Reason” in Article I is intended to meet requirements so that a termination for Good Reason will constitute an
“involuntary separation” within the meaning of Treasury Regulation § 1.409A-1(n)(2)(i), and shall be so construed and interpreted. 

  

	 	(iii)	Non-transferability. No right to any payment or benefit under this Plan shall be subject to anticipation, alienation, sale, transfer, assignment, pledge, encumbrance,
attachment, or garnishment by Participant’s creditors or of any of Participant’s beneficiaries. 

  

	 	(iv)	No Acceleration. The timing of payments and benefits under the Plan may not be accelerated to occur before the time specified for payment hereunder, except to the extent
permitted under Treasury Regulation § 1.409A-3(j)(4) or as otherwise permitted under Code Section 409A without Participant incurring a tax penalty. 

 Section 4.8 Accelerated Vesting of Certain Stock Options. 
 In the event that a Participant becomes eligible to receive a Cash Severance Payment under Section 4.2, then any stock option granted to the Participant
by the Company on or after July 1, 2007, which option remains outstanding immediately before the Participant’s termination of employment but has not yet become vested, other than excluded options as described below, shall not be forfeited upon
the Participant’s termination of employment but instead shall become vested and fully exercisable at the time of such termination, subject to the requirement that the Participant timely execute the Release and deliver it to the Company, and
such Release thereafter becomes effective. Stock options granted by the Company after the effectiveness of this Plan may be excluded from the operation of this Section 4.8 if the Board of Directors or the committee thereof authorizing the grant
specifically provides, in the agreement evidencing the option and delivered to the Participant promptly following the grant of the option, that the option will not be subject to acceleration of vesting under this Section 4.8. 

 ARTICLE V 
 OTHER RIGHTS AND BENEFITS NOT AFFECTED 
 Section 5.1 Other Benefits 
 Subject to Section 4.3 (providing for offsets to payments and benefits under this Plan for severance and benefits under employment agreements and
other arrangements), neither the provisions of this Plan nor the Severance Benefit provided for hereunder shall reduce any amounts otherwise payable, or in any way diminish a Participant’s rights as an employee, whether existing now or
hereafter, under any employee benefit, incentive, retirement, welfare, stock option, stock bonus or stock-based, or stock purchase plan, program, policy or arrangement or any written employment agreement or other plan, program policy or arrangement
not related to severance. 
 Section 5.2 Employment Status 
 This Plan does not constitute a contract of employment or impose on a Participant any obligation to remain in the employ of the Company, nor does it
impose on the Company any obligation to retain a Participant in his or her present or any other position, nor does it change the status of a Participant’s employment as an employee at will (or otherwise). Nothing in this Plan shall impairs the
right of the Company in its absolute discretion to change or reduce a Participant’s compensation at any time, or to change or terminate at any time one or more of its employee benefit plans, except for compensation payable under the terms of
this Plan. 
 ARTICLE VI 
 SUCCESSOR TO THE COMPANY 
 The Company shall require any successor or assignee, whether direct or indirect, by purchase,
merger, consolidation or otherwise, to all or substantially all the business or assets of the Company, unconditionally to assume and agree to perform the Company’s obligations under this Plan, in the same manner and to the same extent that the
Company would be required to perform if no succession or assignment had taken place. In such event, the term “Company”, as used in this Plan, shall mean (from and after, but not before, the occurrence of such event) the Company as herein
before defined and any successor or assignee to the business or assets which by reason hereof becomes bound by the terms and provisions of this Plan. 
 ARTICLE VII 
 CLAIMS 
 Section 7.1 Claims Procedure 
 If a Participant has (a) a claim for compensation or benefits which are not being paid under the Plan, (b) another claim for benefits under the Plan, or (c) a claim for clarification of rights under this Plan, then such
Participant (or his or her designee) (a “Claimant”) may file with the Committee a written claim setting forth the amount and nature of the claim, supporting facts, and the Claimant’s address. The Committee shall notify each Claimant
of its decision in writing by written or electronic means within 90 days after its receipt of a claim, unless otherwise agreed 

 
by the Claimant. In special circumstances, the Committee may extend for a further 90 days the deadline for its decision, provided the Committee notifies the
Claimant of the need for the extension within 90 days after its receipt of a claim. If a claim is denied, the written notice of denial shall set forth the reasons for such denial, refer to pertinent provisions of the Plan on which the denial is
based, describe any additional material or information necessary for the Claimant to realize the claim, and explain the claims review procedure under the Plan and a statement of a Participant’s right to bring a cause of action under
Section 502(a) of ERISA after receiving a denial upon appeal. 
 Section 7.2 Claims Review Procedure 
 A Claimant whose claim has been denied or such Claimant’s duly authorized representative may file, within 60 days after notice of such denial is
received by the Claimant, a written request for review of such claim by the Committee. If a request is so filed, the Committee shall review the claim and notify the Claimant in writing of its decision within 60 days after receipt of such request,
unless otherwise agreed by the Claimant. In special circumstances, the Committee may extend for up to 60 additional days the deadline for its decision, provided the Committee notifies the Claimant of the need for the extension within 60 days after
its receipt of the request for review. The notice of the final decision of the Committee shall include the reasons for its decision, specific references to the Plan on which the decision is based and a statement of a Participant’s right to
receive, upon request and without charge, reasonable access to and copies of all documents, records and other information relevant to the claim for benefits. The decision of the Committee shall be final and binding on all parties. 
 ARTICLE VIII 
 ADMINISTRATION 

 Section 8.1 Committee 
 The Chief Executive Officer of the Company (the “CEO”) shall appoint not less than three (3) members of a committee, to serve at the pleasure of the CEO to administer the Plan. Members of the Committee
may but need not be employees of the Company and may but need not be participants in the Plan, but a member of the Committee who is eligible to participate in the Plan shall not vote or act upon any matter which relates solely to such member as a
Plan participant. All decisions of the Committee shall be by a vote or written evidence of intention of the majority of its members and all decisions of the Committee shall be final and binding. 
 Section 8.2 Committee Membership 
 Any member of the Committee may resign at any time by giving thirty (30) days’ advance written notice to the CEO and to the remaining members (if any) of the Committee. A member of the Committee, who at the time of his or her
appointment to the Committee was an employee or director of the Company, and who for any reason ceases to be neither an employee nor a director, as applicable, of the Company, shall cease to be a member of the Committee effective on the date he or
she ceases to be neither an employee nor director, as applicable, of the Company unless the CEO affirmatively continues his or her appointment as a member of the Committee. If there is a vacancy in the membership of the Committee, the remaining
members 

 
shall constitute the full Committee. The CEO may fill any vacancy in the membership of the Committee, or enlarge the Committee, by giving written notice of
appointment to the person so appointed and to the other members (if any) of the Committee, effective as stated in such written notice. However, the CEO shall not be required to fill any vacancy in the membership of the Committee if there remain at
least three members of the Committee. Any notice required by this Section may be waived by the person entitled thereto. 
 Section 8.3 Duties 
 Except as otherwise provided herein, the Committee shall have the power and duty in its sole
and absolute discretion to do all things necessary or convenient to effect the intent and purposes of the Plan, whether or not such powers and duties are specifically set forth herein, and, by way of amplification and not limitation of the
foregoing, the Committee shall have the power in its sole and absolute discretion to: 
 (a) provide rules for the management,
operation and administration of the Plan, and, from time to time, amend or supplement such rules; 
 (b) interpret and
construe the Plan in its sole and absolute discretion to the fullest extent permitted by law, which interpretation and construction shall be final and conclusive upon all persons; 
 (c) correct any defect, supply any omission, or reconcile any inconsistency in the Plan in such manner and to such extent as it shall deem
appropriate in its sole discretion to carry the same into effect; 
 (d) make all determinations relevant to eligibility for
benefits under the Plan, including determinations as to: whether a Participant has incurred a termination of employment, the existence of Cause or Good Reason, whether the amounts or benefits to be provided under the Plan would be subject to
additional taxes and penalties under Section 409A of the Code, and compliance with applicable restrictive covenants; 
 (e) enforce the Plan in accordance with its terms and the Committee’s interpretation or construction of the Plan as provided in subsection (b) above; and 
 (f) do all other acts and things necessary or proper in its judgment to carry out the purposes of the Plan in accordance with its terms
and intent. 
 The Committee shall have the authority to adopt, alter and repeal such administrative rules, guidelines and practices
governing the Plan as it shall, from time to time, deem advisable, to interpret the terms and provisions of the Plan and to otherwise supervise the administration of the Plan. 

 ARTICLE IX 
 MISCELLANEOUS 
 Section 9.1 Applicable Law 
 This is an employee benefit plan subject to ERISA and shall be governed by and construed in accordance with ERISA and, to the extent applicable and not
preempted by ERISA, the law of the State of Delaware applicable to contracts made and to be performed entirely within that State, without regard to its conflict of law principle. 
 Section 9.2 Construction 
 No term or provision of this Plan shall be construed so as to require the commission of any act contrary to law, and wherever there is any conflict between any provisions of this Plan and any present or future law, ordinance, or regulation,
the latter shall prevail, but in such event the affected provision of this Plan shall be curtailed and limited only to the extent necessary to bring such provision with the requirements of the law. 
 Section 9.3 Severability; Equitable Modification 
 If a provision of this Plan shall be held illegal or invalid, the illegality or invalidity shall not affect the remaining parts of this Plan and this Plan shall be construed and enforced as if the illegal or invalid
provision had not been included. If any court of competent jurisdiction shall deem any provision of the Agreement too restrictive, the other provisions shall stand, and the court shall modify the provision at issue to the point of greatest
restriction permissible by law. 
 Section 9.4 Headings 
 The Section headings in this Plan are inserted only as a matter of convenience of reference, and in no way define, limit, or extend or interpret the scope
of this Plan or of any particular Section. 
 Section 9.5 Assignability 
 A Participant’s rights or interests under this Plan shall not be assignable or transferrable (whether by pledge, grant of a security interest, or
otherwise), except by will or by the laws of descent and distribution. 
 Section 9.6 No Waiver 
 Any waiver of breach of any of the terms, provisions, or conditions of this Agreement must be in writing to be effective, and shall not be construed or
held to be a waiver of any other breach, or a waiver of, acquiescence in, or consent to any further succeeding breach thereof. 
 Section 9.7 Term 
 This Plan shall continue in full force and effect until its terms and provisions are
completely carried out, unless terminated by the Board with at least a majority vote before the commencement of a Change in Control Period (as defined below). A “Change in Control Period” shall commence upon the earlier of (i) the
first day the Company (or any Person on its behalf) begins negotiations to effect a Change in Control and (ii) the Company executing a letter of intent (whether or not binding) or a definitive agreement to effect a Change in Control and shall
expire upon the first to occur of (A) the occurrence of a Change in Control and (B) the first anniversary of the commencement of the Change in Control Period. 

 Section 9.8 Amendment/Termination 
 This Plan may be amended in any respect by resolution adopted by the Board until the commencement of a Change in Control Period; provided, however, that
this Section 9.8 shall not be amended, and no amendment to the Plan shall be effective if made during a Change in Control Period except to the extent that such amendment is agreed to by the affected Participants in writing. After a Change in
Control occurs, this Plan shall no longer be subject to amendment, change, substitution, deletion, revocation or termination in any respect whatsoever until the second anniversary of such Change in Control. No agreement or representations, written
or oral, express or implied, with respect to the subject matter hereof, have been made by the Company which are not expressly set forth in this Plan. Amendment or termination of the Plan shall not accelerate (or defer) the time of any payment under
the Plan that is deferred compensation subject to Section 409A of the Code if such acceleration (or deferral) would subject such deferred compensation to additional tax or penalties under Section 409A. 
 Section 9.9 Notices 
 For
purposes of this Plan, notices and all other communications provided for herein shall be in writing and shall be deemed to have been duly given when personally delivered, or sent by certified or overnight mail, return receipt requested, postage
prepaid, addressed to the respective addresses last given by each party to the other, provided that all notices to the Company shall be directed to the attention of the Board. All notices and communications shall be deemed to have been received on
the date of delivery thereof if personally delivered, on the third business day after the mailing thereof, or on the date after sending by overnight mail, except that notice of change of address shall be effective only upon actual receipt. No
objection to the method of delivery may be made if the written notice or other communication is actually received. 
 Section 9.10
Exculpation 
 To the extent permitted by applicable law, no member of the Committee serving as Plan administrator nor any other
officer, employee or director of the Company acting on behalf of the Company with respect to this Plan shall be directly or indirectly responsible or otherwise liable by reason of any action or default as a member of that Committee, Plan
administrator or other officer or employee of the Company acting on behalf of the Company with respect to this Plan, or by reason of the exercise of or failure to exercise any power or discretion as such person, except for any action, default,
exercise or failure to exercise resulting from such person’s gross negligence or willful misconduct. To the extent permitted by applicable law, no member of the Committee shall be liable in any way for the acts or defaults of any other member
of the Committee, or any of its advisors, agents or representatives. 
 Section 9.11 Indemnification 
 The Company shall indemnify and hold harmless each member of the Committee serving as Plan administrator, and each other officer, employee or director of
the Company acting on behalf of the Company with respect to this Plan, against any and all expenses and liabilities 

 
arising out of his or her own membership on the Committee, service as Plan administrator, or other actions respecting this Plan on behalf of the Company,
except for expenses and liabilities arising out of such person’s gross negligence or willful misconduct. A person indemnified under this Section who seeks indemnification hereunder (“Indemnitee”) shall tender to the Company a request
that the Company defend any claim with respect to which the Indemnitee seeks indemnification under this Section and shall fully cooperate with the Company in the defense of such claim. If the Company shall fail to timely assume the defense of such
claim, then the Indemnitee may control the defense of such claim. However, no settlement of any claim otherwise indemnified under this Section shall be subject to indemnity hereunder unless the Company consents in writing to such settlement.

 Section 9.12 Information 
 The Company and the Participant shall furnish to the Committee in writing all information the Committee may deem appropriate for the exercise of their powers and duties in the administration of the Plan. Such
information may include, but shall not be limited to, the names of all Plan participants, their earnings and their dates of birth, employment, termination or death. Such information shall be conclusive for all purposes of the Plan, and the Committee
shall be entitled to rely thereon without any investigation thereof. 
 Section 9.13 No Property Interest 
 The Plan is unfunded. Severance pay shall be paid exclusively from the general assets of the Company and any liability of the Company to any person with
respect to benefits payable under the Plan shall give rise solely to a claim as an unsecured creditor against the general assets of the Company. Any claim a Participant may have, or any interest in or right to any compensation, payment or benefit
payable hereunder, shall rely solely upon the unsecured promise of the Company for the payment thereof, and nothing herein contained shall be construed to give to or vest in a Participant or any other person now or at any time in the future, any
right, title, interest or claim in or to any specific asset, fund, reserve, account, insurance or annuity policy or contract, or other property of any kind whatsoever owned by the Company, or in which the Company may have any right, title or
interest now or at any time in the future. 
 Section 9.14 Beneficiary 
 Any payment due under this Plan after a Participant’s death shall be paid to such person or persons, jointly or successively, as such Participant may
designate, in writing filed with the Committee during such Participant’s lifetime in a form acceptable to the Committee, which a Participant may change without the consent of any beneficiary by filing a new designation of beneficiary in like
manner. If no designation of beneficiary is on file with the Committee or no designated beneficiary is living or in existence upon such Participant’s death, such payments shall be made to such Participant’s surviving spouse, if any, or if
none, to such Participant’s estate. 
 Section 9.15 Plan Year 
 The fiscal records of the Plan shall be kept on the basis of a plan year which is the calendar year. 
 *        *        * 
 Dated: January 10, 2008 

 Exhibit A 
 Restrictive Covenants Agreement 
  

 A-1 

 Exhibit B 
 Separation and General Release Agreement 
 IPC The Hospitalist Company (“Company”),
and                                  (“Employee”), agree that this
Separation Agreement and General Release (“Agreement”) sets forth their complete agreement and understanding regarding the termination of Employee’s employment with Company. 
 1. Separation Date. Employee’s employment with Company will terminate/was terminated effective
                     (the “Separation Date”). Employee represents that the Employee has returned all Company property to Company.
Except as specifically provided below, Employee shall not be entitled to receive any benefits of employment following the Separation Date. 
 2. Consideration of Company. In consideration for the releases and covenants by Employee in this Agreement, Company will provide Employee with: describe severance benefits. 
 3. Employee Release of Rights and Agreement Not to Sue. Employee (defined for the purpose of this Paragraph 3 as Employee and Employee’s
agents, representatives, attorneys, assigns, heirs, executors, and administrators) fully and unconditionally releases the Released Parties (defined as the Company and any of its past or present employees, agents, insurers, attorneys, administrators,
officials, directors, shareholders, divisions, parents, subsidiaries, predecessors, successors, employee benefit plans, and the sponsors, fiduciaries, or administrators of the Company’s employee benefit plans) from, and agrees not to bring any
action, proceeding or suit against any of the Released Parties regarding, any and all known or unknown claims, causes of action, liabilities, damages, fees, or remunerations of any sort, arising or that may have arisen out of or in connection with
Employee’s employment with or termination of employment from the Company, including but not limited to claims for: 
 (a) violation of
any written or unwritten contract, agreement, policy, benefit plan, retirement or pension plan, option plan, severance plan, or covenant of any kind, or failure to pay wages, bonuses, employee benefits, other compensation, attorneys’ fees,
damages, or any other remuneration; and/or 
 (b) discrimination, harassment, or retaliation on the basis of any characteristic protected
under law, including but not limited to race, color, national origin, sex, sexual orientation, religion, disability, marital or parental status, age, union activity or other protected activity; and/or 
 (c) denial of protection or benefits under any statute, ordinance, executive order, or regulation, including but not limited to claims under Title VII of
the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Civil Rights Act of 1866, the Age Discrimination in Employment Act, the Americans with Disabilities Act, the Fair Labor Standards Act, the Family and Medical Leave Act, the
Workers’ Adjustment and Retraining Notification, the Employee Retirement Income Security Act of 1974, the Illinois Wage 

  

 B-2 

 
Payment and Collection Act, the Illinois Human Rights Act, or any other federal, state or local statute, ordinance, or regulation regarding employment,
termination of employment, or discrimination in employment; and/or 
 (d) violation of any public policy or common law of any state relating
to employment or personal injury, including but not limited to claims for wrongful discharge, defamation, invasion of privacy, infliction of emotional distress, negligence, interference with contract. 
 4. No Disparagement or Encouragement of Claims. Except as required by lawful subpoena or other legal obligation, Employee agrees not to
make any oral or written statement that disparages or places the Company (including any of its past or present officers, employees, products or services) in a false or negative light, or to encourage or assist any person or entity who may or who has
filed a lawsuit, charge, claim or complaint against the Released Parties (as defined in Paragraph 3, above). Employee affirms that Employee has not done anything before signing this Agreement that would violate this paragraph. If Employee receives
any subpoena or becomes subject to any legal obligation that implicates this paragraph, Employee will provide prompt written notice of that fact to the Company (as provided below) and enclose a copy of the subpoena and any other documents describing
the legal obligation. [OPTIONAL] 
 5. Non-admission/Inadmissibility. This Agreement does not constitute an admission that the
Company took any wrongful, unlawful, or harmful action, and the Company specifically denies any wrongdoing. This Agreement is offered solely to resolve fully all matters related to Employee’s employment with and termination from Company. This
Agreement shall not be used as evidence in any proceeding, except one alleging a breach of this Agreement. 
 6. Severability.
The provisions of this Agreement shall be severable such that the invalidity of any provision shall not affect the validity of other provisions; provided, however, that if a court or other binding authority holds that any release in Paragraph 3
is illegal, void or unenforceable, Employee agrees to promptly execute a release and agreement that is legal and enforceable. 
 7.
Governing Law. This Agreement shall be governed by and construed in accordance with Delaware law, without regard to its principles of conflicts of laws. 
 8. Entire Agreement. This Agreement represents the entire agreement and understanding concerning Employee’s separation from the Company. This Agreement supersedes and replaces any and all prior agreements,
understandings, discussions, negotiations, or proposals concerning the matters addressed herein; provided, however, that the Company’s Executive Change in Control Plan, including without limitation Employee’s obligations thereunder and the
applicable restrictive covenants to which the Employee is bound, shall remain in full force and effect. In deciding to sign this Agreement, Employee has not relied on any express or implied promise, statement, or representation by the Company,
whether oral or written, except as set forth herein. 
  

 B-3 

 9. [FOR EMPLOYEES AGE 40+ ONLY] Revocation Period. Employee has the right to revoke this
Agreement, solely with regard to Employee’s release of claims under the Age Discrimination in Employment Act and the Older Workers Benefit Protection Act, for up to seven days after Employee signs it. In order to revoke this Agreement, Employee
must sign and send a written notice of the decision to do so, addressed to [insert title, and address], and that written notice must be received by the Company no later than the eighth day after Employee signed this Agreement. If
Employee revokes this Agreement, Employee will not be entitled to any of the consideration from the Company described in paragraph 2 above or under the Company’s Change in Control Plan. 
 10. Voluntary Execution of Agreement. Employee acknowledges that: 
  

	 	a.	Employee has carefully read this Agreement and fully understands its meaning; 

  

	 	b.	Employee had the opportunity to take up to 21 days [45 days for those age 40+ discharged in a termination affecting more than 1 employee] after receiving this Agreement to
decide whether to sign it; 

  

	 	c.	Employee understands that the Company is herein advising him, in writing, to consult with an attorney before signing it; 

  

	 	d.	Employee is signing this Agreement, knowingly, voluntarily, and without any coercion or duress; and 

  

	 	e.	everything Employee is receiving for signing this Agreement is described in the Agreement itself, and no other promises or representations have been made to cause Employee to sign
it. 

  

							
		 		  	IPC The Hospitalist Company
			
	  
	  	By:	  	  

	Employee Signature	  		  	
			
	  
	  	Title:	  	  

	Employee Name (print)	  		  	
				
	Dated:	 	  
	  	Dated:	  	  

  

 B-4Second Amended and Restated Registration Agreement

 Exhibit 10.17 
 SECOND AMENDED AND RESTATED 
 REGISTRATION RIGHTS AGREEMENT 
 THIS SECOND AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of October 7,2002, is made by and among
Bank of America Ventures, a California corporation (“BAV”), BA Venture Partners V, a Delaware I general partnership (“BAVP” and together with BAV, “BA”), CB Healthcare Fund, L.P., a Delaware limited partnership
(“CB”), Morgenthaler Venture Partners IV, L.P., a Delaware limited partnership (“MVPIV”), Morgenthaler Partners VII, L.P., a Delaware limited partnership (“MVPVI”, and together with MVPIV, “MVP”), Bessemer
Venture Partners IV L.P., a Delaware limited partnership (“BVP”), Bessemer Venture Investors L.P., a Delaware limited partnership (“BVI”) and Bessec Ventures IV L.P., a Delaware limited partnership (“BV” and together
with BVI and BVP, “Bessemer”), Crucible Partners L.P. I, a Delaware limited partnership (“Crucible”), U.S. Bancorp Piper Jaffray Inc., a Delaware corporation (“Piper”), NSE Investments, LLC, a California limited
liability company (“NSE), Patrick Holmes (all of the above collectively, the “Investors”), Inpatient Consultants Management, Inc., a Delaware corporation (the “Company”), and at least a majority of the Founder Shareholders
(as defined in Section 16(j) below) of the Company, with reference to the following: 
 A. The Company, the Investors, Adam Singer, M.D.,
Steven Taback, M.D., James Roach, M.D. and Robert Singer are parties to that certain Amended and Restated Registration Rights Agreement dated as of December 15, 2000 (the “Registration Rights Agreement”). 
 B. BA, MVP, BVP, BV, CB and the Company have entered into a Series D Preferred Share and Warrant Purchase Agreement of even date herewith (the
“Share Purchase Agreement”) pursuant to which BA, MVP, BVP, BV and CB have agreed to acquire Series D Convertible Preferred Stock of the Company (“Series D Shares”), together with warrants to purchase additional Series D Shares
(the “Warrants”). 
 C. The execution and delivery of this Agreement is a condition to the consummation of the transactions
contemplated by the Share Purchase Agreement. 
 D. The parties to the Registration Rights Agreement desire to amend and restate the
Registration Rights Agreement and accept the rights and covenants hereof in lieu of their right and covenants under the Registration Rights Agreement. 
 E. The Registration Rights Agreement provides that it may be amended by a writing signed by the
holders of at least sixty-six and two-thirds percent (66 2/3%) of the Company’s then-outstanding Preferred
Stock and by Founder Shareholders holding at least fifty-one percent (51%) of all shares of Common Stock of the Company held by the Founder Shareholders. 
 NOW, THEREFORE, the parties to this Agreement hereby agree that the Registration Rights Agreement is hereby amended and restated in its entirety to read as follows: 
 1. Required Registration. Upon the receipt by the Company, from Investors holding at least fifty percent (50%) of the Common Shares (as
defined in Section 16(h) below) held by all of the Investors, of a written request (the “Request”) for the registration of Common Shares owned by such Investors at any time and from time to time after the earlier of (i) six
(6) months 

 
after the date on which the Company completes an initial public offering (the “Initial Offering”) of its capital stock pursuant to a registration
statement filed with the Securities and Exchange Commission (“SEC”) under the Securities Act of 1933, as amended (the “1933 Act”), and (ii) December 3 1, 2004, the Company shall prepare and file a registration statement
under the 1933 Act covering the Common Shares which are the subject of the Request. The Company shall promptly give written notice to all Investors of its receipt of a Request, and the Company shall include in such registration statement all other
Common Shares which such Investors have requested to have included within twenty (20) days after such notice has been given by the Company. The Investors shall be entitled to two (2) registrations under this Section 1. In the event
that the Investors delivering the Request determine for any reason (other than at the request or recommendation of the Company or the managing underwriters) not to proceed with a registration of Common Shares requested pursuant to this
Section 1 at any time before the registration statement has been declared effective by the SEC, and such registration statement, if theretofore filed with the SEC, is withdrawn with respect to the Common Shares covered thereby, and such
Investors agree to reimburse the Company for the fees, costs and expenses incurred by it in connection therewith, then the Investors shall not be deemed to have exercised one (1) of their rights to require the Company to register Common Shares
pursuant to this Section 1. If the Investors determine not to proceed with such a registration upon the written request or recommendation of the Company or the managing underwriters, the Investors shall not be required to reimburse the Company
for its fees, costs and expenses and the Investors shall not be deemed to have exercised one (1) of their rights to require the Company to register Common Shares pursuant to this Section 1. The Company shall not, without the prior written
consent of Investors holding at least fifty percent (50%) of the Common Shares then held by all of the Investors, effect any registration of its securities (other than on Form S-4 or Form S-8) from the date the Company receives a Request
pursuant to this Section 1 until the earlier of (a) ninety (90) days after the date on which all securities covered by such Request have been sold or (b) one hundred eighty (180) days after the effective date of the
registration statement covering such securities. 
 2. Incidental Registration. Each time the Company shall determine to
proceed with the preparation and filing of a registration statement under the 1933 Act in connection with the proposed offer and sale for money of any of its securities, whether by the Company or any of its security holders (other than on Forms S-4
or S-8, or any successor or similar form), the Company shall give written notice of its determination to each of the Investors. Upon the Request of an Investor given to the Company within thirty (30) days after the mailing of any such notice by
the Company, the Company shall, subject to Section 5 hereof, cause all such Common Shares which such Investor has requested to be registered to be included in such registration statement. 
 3. Short Form Registration. In addition to the registration rights provided in Sections 1 and 2 hereof, if the Company qualifies for the
use of Form S-3 or any similar short form registration statement then in effect (other than on Form S-4 or Form S-8), upon the receipt by the Company from Investors holding at least twenty-five percent (25%) of the Common Shares then held by
all of the Investors of a Request for the registration of Common Shares held by such Investors, the Company shall register Common Shares on such form on behalf of Investors at the Request of Investors. All registrations effected under this
Section 3 shall be at the expense of the Company. The Investors shall be entitled to a total of two (2) registrations under this Section 3, of which no more than one (1) shall be effected in any twelve (12) month period. In
the event 

 
that the Investors delivering the Request determine for any reason (other than at the written request or recommendation of the Company or the managing
underwriters) not to proceed with a registration of Common Shares requested pursuant to this Section 3 at any time before the registration statement has been declared effective by the SEC, and such registration statement, if theretofore filed
with the SEC, is withdrawn with respect to the Common Shares covered thereby, and such Investors shall reimburse the Company for the fees, costs and expenses incurred by it in connection therewith, then the Investors shall not be deemed to have
exercised one (1) of their rights to require the Company to register Common Shares pursuant to this Section 3. If the Investors determine not to proceed with such a registration upon the written request or recommendation of the Company or
the managing underwriters, the Investors shall not be required to reimburse the Company for its fees, costs and expenses and the Investors shall not be deemed to have exercised one (1) of their rights to require the Company to register Common
Shares pursuant to this Section 3. 
 4. Limitations. Notwithstanding the provisions of Sections 1 and 3 hereof
(a) the Company shall have the right to delay or suspend the preparation and filing of a registration statement for up to one hundred twenty (120) days if in the reasonable judgment of a majority of the Directors on the Board of Directors
of the Company such preparation or filing would harm or hinder in any material fashion the ability of the Company to conduct its affairs or would have a material adverse effect on the business, properties or financial condition of the Company;
provided that the Company shall use its best efforts to cause any such registration statement to become effective within one hundred eighty (180) days of receipt of the Request therefor and shall only be entitled to utilize this clause
(a) once in any twelve (12) month period; (b) if, prior to receiving a Request for registration, the Company has given notice under Section 2 hereof that it intends to prepare and file a registration statement (a
“Section 2 Registration Statement”), then the Company shall have the right to delay or suspend the filing of the registration statement requested by the Investors; provided that the Company shall use its best efforts to cause any such
registration statement requested by the Investors to become effective within one hundred eighty (180) days (or, if required by the underwriters for the Section 2 Registration Statement, within two hundred seventy (270) days) after the
date on which all securities covered by the Section 2 Registration Statement have been sold, and that the Company shall use its best efforts to include any Common Shares that are the subject of a Request delivered by Investors under
Section 2 in such Section 2 Registration Statement; (c) the Company shall not be required to prepare or file a registration statement with respect to any Request under Section 1 if the reasonably anticipated offering price of the
Common Shares covered thereby is less than Five Million Dollars ($5,000,000); and (d) the Company shall not be required to prepare or file a registration statement with respect to any Request under Section 3 if the reasonably
anticipated offering price of the Common Shares covered thereby is less than Five Hundred Thousand Dollars ($500,000). 
 5. Pro
Ration. If Common Shares (including any Common Shares of the Company) are to be included under Sections 1, 2 or 3 above in a registration statement which pertains to one (1) or more underwritten public offerings and the managing
underwriters advise the Company in writing that in their opinion the number of Common Shares requested to be included exceeds the number of Common Shares which can be sold in such offering without materially and adversely affecting the success of
such offering, the Company will include in such registration only such number of Common Shares which in the opinion of such underwriters can be sold without any such material adverse effect, selected in the following order of priority:
(i) first, such Common 

 
Shares as to which registration rights have been exercised by the Investor(s) under Section 1 or 3, as the case may be (the “Demand Shares”),
on a pro rata basis among the holders of Demand Shares according to the relation that the number of Common Shares owned by each such holder bears to the total number of Common Shares owned by all such holders; (ii) second, the Common Shares
which the Company proposes to issue and sell; (iii) third, the number of Common Shares requested by the Investors (to the extent their request was not pursuant to Section 1 or 3) to be included which in the opinion of such underwriters can
be sold without any such material adverse effect (the “Secondary Shares”), on a pro rata basis among holders of such Secondary Shares according to the relation that the number of Common Shares owned by each such holder bears to the total
number of Common Shares owned by all such holders (exclusive of Demand Shares in each case); provided, however, that the Secondary Shares shall be no less than twenty-five percent (25%) of the total number of Common Shares included in such
offering, unless such offering is the Initial Offering and such registration does not include shares of any other selling stockholders, in which event any or all of the Common Shares of the Investors may be excluded; and (iv) fourth, any other
Common Shares requested to be included in such registration statement by persons other than the Investors. Notwithstanding the foregoing, in no event will shares of any other selling stockholder be included in such registration that would reduce the
number of shares which may be included by the Investors without the written consent of holders of not less than sixty-six and two-thirds percent (66 2/3%) of the Common Shares proposed to be sold in the offering. 
 6. Registration
Procedures. If and whenever the Company is required by the provisions of Sections 1, 2 or 3 to effect the registration of Common Shares under the 1933 Act, the Company will: 
 (a) subject to the provisions of Section 4, prepare and file with the SEC within forty-five (45) days of the Company’s receipt of an
Investor’s Request (or other request therefor) a registration statement with respect to such Common Shares, and use its best efforts to cause such registration statement to become effective within one hundred (100) days of the
Company’s receipt of such Request and remain effective for such period as may be reasonably necessary to effect the sale of such Common Shares, not to exceed six (6) months (this provision shall not be applicable to
registrations pursuant to Section 2); 
 (b) prepare and file with the SEC such amendments to such registration statement and
supplements to the prospectus contained therein as may be necessary to keep such registration statement effective until the earlier of (i) the date on which all Common Shares covered by such registration statement have been sold and
(ii) one hundred eighty (180) days after the effective date of such registration statement; 
 (c) use its best efforts to register
or qualify the Common Shares for sale under such other securities or blue sky laws of such jurisdictions as the Investors may reasonably request (including factors such as the cost to the Company) and do any and all other acts and things which may
be reasonably necessary or desirable to enable the Investors to consummate the disposition of the Common Shares in such jurisdictions; 
 (d)
furnish to the Investors and to the underwriters of the securities being registered a reasonable number of copies of the registration statement, preliminary prospectus, final prospectus and such other documents as the Investors or underwriters may
reasonably request in order to facilitate the public offering of such securities; 

 (e) notify the participating Investors, promptly after it shall receive notice thereof, of the time when
such registration statement has become effective or a supplement to any prospectus forming a part of such registration statement has been filed; 
 (f) notify the Investors promptly of any request by the SEC for the amending or supplementing of such registration statement or prospectus or for additional information; 
 (g) prepare and file with the SEC, promptly upon the request of the Investors, any amendments or supplements to such registration statement or prospectus
which, in the opinion of counsel for the Investors (and concurred in by counsel for the Company), is required under the 1933 Act or the rules and regulations thereunder in connection with the distribution of the Common Shares by the Investors;

 (h) prepare and promptly file with the SEC, and promptly notify the Investors of the filing of, any amendment or supplement to such
registration statement or prospectus as may be necessary to correct any statements or omissions if, at the time when a prospectus relating to such securities is required to be delivered under the 1933 Act, any event shall have occurred as the result
of which any such prospectus or any other prospectus as then in effect would include an untrue statement of a material fact or omit to state any material fact necessary to make the statement therein, in the light of the circumstances in which they
were made, not misleading; 
 (i) advise the Investors, promptly after it shall receive notice or obtain knowledge thereof, of the issuance
of any stop order by the SEC suspending the effectiveness of such registration statement or the initiation or threatening of any proceeding for that purpose and promptly use its best efforts to prevent the issuance of any stop order or to obtain its
withdrawal if such stop order should be issued; 
 (j) at least three (3) days prior to the filing of any amendment or supplement to
such registration statement or prospectus, furnish copies thereof to the Investors and refrain from filing any such amendment or supplement to which the Investors shall have reasonably objected on the grounds that such amendment or supplement does
not comply in all material respects with the requirements of the 1933 Act or the rules and regulations thereunder, unless in the opinion of counsel for the Company the filing of such amendment or supplement is reasonably necessary to protect the
Company from any liabilities under any applicable federal or state law and such filing will not violate applicable law; and 
 (k) at the
request of the Investors, furnish on the date or dates provided for in the underwriting agreement: (i) an opinion of counsel for the Company addressed to the underwriters, if any, and to the Investors making the Request, opining as to such
matters as may be reasonably agreed to by such underwriters and the Company; and (ii) a letter or letters from the independent certified public accountants of the Company, addressed to the underwriters, if any, and to the Investors making the
Request, covering such matters as such underwriters request, in which letters such accountants shall state (without limiting the generality of the foregoing) that they are independent certified public accountants within the meaning of the 1933

 
Act and that in the opinion of such accountants the financial statements and other financial data of the Company included in the registration statement or
any amendment or supplement thereto comply in all material respects with the applicable accounting requirements of the 1933 Act. 
 7.
Expenses. With respect to the registrations requested pursuant to Section 1 hereof, and with respect to each inclusion of Common Shares in a registration statement pursuant to Section 2 hereof, and with respect to all
registrations requested pursuant to Section 3 hereof, the Company shall bear the reasonable fees, costs and expenses of such registrations, including but not limited to the following fees, costs and expenses: all registration, filing and stock
exchange fees, printing expenses, fees and disbursements of counsel and accountants for the Company, fees and disbursements of other service providers retained by the Company, all legal fees and disbursements and other expenses of complying with
state securities or blue sky laws of any jurisdictions in which the securities to be offered are to be registered or qualified and the reasonable fees and disbursements of one (1) counsel for all Investors participating in such registration.
The Investors participating in such registration shall be responsible for, and shall pay, their pro rata share of underwriting discounts and commissions with respect to the Common I Shares being sold by them. 
 8. Termination of Registration Rights. All registration rights granted pursuant to Sections 1 and 2 hereof shall terminate and be of no
further force and effect five (5) years after the date of the Company’s Initial Offering. In addition, an Investor’s registration rights granted under this Agreement shall expire if (a) the Company has completed its Initial
Offering and is subject to the provisions of the Securities Exchange Act of 1934, as amended, (b) such Investor (together with its affiliates) as reflected on the Company’s list of stockholders holds less than 1% of the then outstanding
Common Shares and (c) all Common Shares held by and issuable to such Investor (and its affiliates) may be sold pursuant to Rule 144 during any ninety (90) day period. 
 9. Indemnification. 
 (a)
By the Company. The Company shall indemnify and hold harmless each holder of Common Shares that are included in a registration statement pursuant to this Agreement and any underwriter (as defined in the 1933 Act) for such holder, the
partners, members, officers and directors of such holder, and each Person, if any, who controls such holder or such underwriter within the meaning of the 1933 Act (collectively, the “Covered Persons”), from and against any and all loss,
damage, liability or claims, to which such Covered Persons become subject under the 1933 Act or otherwise, and subject to the provisions of Section 9(c) hereof to reimburse them, from time to time upon request, for any legal or other costs or
expenses reasonably incurred by them in connection with investigating any claims or defending any actions (as provided in Section 9(c) hereof), insofar as such losses, damages, liabilities, claims, costs or expenses are caused by any untrue
statement or alleged untrue statement of any material fact contained in such registration statement, any prospectus contained therein or any amendment or supplement thereto or arise out of or are based upon the omission or alleged omission to state
therein a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances in which they were made, not misleading, or any violation of the 1933 Act, the Securities Exchange Act of 1934, as
amended (the “Exchange Act”) or any state securities laws or any rule or regulation promulgated thereunder; provided, however, that the Company will not be liable in any such case to the extent that any such loss, 

 
damage, liability, claim, cost or expense arises out of or is based upon (i) an untrue statement or alleged untrue statement or omission or alleged
omission (other than a statement or omission about the Company) made in conformity with information diminished by the Investors in writing specifically for use in the preparation of such registration statement or (ii) the holders’ failure
to deliver a copy of the registration statement, prospectus or any amendments or supplements thereto. 
 (b) By Holders of Common
Shares. Each holder of Common Shares that are included in a registration pursuant to this Agreement will indemnify and hold harmless the Company, any underwriter and each person, if any, who controls the Company or such underwriter,
severally and not jointly, from and against any and all loss, damage, liability or claims to which the Company or any controlling person and/or any underwriter becomes subject under the 1933 Act or otherwise and to reimburse them, from time to time
upon request, for any legal or other costs or expenses reasonably incurred by them in connection with investigating any claims or defending any actions, insofar as such losses, damages, liabilities, costs or expenses are caused by any untrue or
alleged untrue statement of any material fact contained in such registration statement, any prospectus contained therein or any amendment or supplement thereto or arise out of or are based upon the omission or the alleged omission to state therein a
material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances in which they were made, not misleading, or any violation of the 1933 Act, the Exchange Act or any state securities laws or any
rule or regulation promulgated thereunder, in each case to the extent, but only to the extent, that such untrue statement or alleged untrue statement or omission or alleged omission was so made in reliance upon and in strict conformity with written
information furnished by such holder specifically for use in the preparation of such registration statement; provided, however, that the indemnity agreement set forth in this Section 9(b) shall not apply to amounts paid in settlement of any
such claim, loss, damage, liability or action if such settlement is effected without the consent of the holder, which consent shall not be unreasonably withheld; provided, that in no event shall any indemnity under this Section 9(b) exceed the
net proceeds from the offering received by such holder. 
 (c) Notice. Promptly after receipt by an indemnified party pursuant
to the provisions of paragraph (a) or (b) of this Section 9 of notice of the commencement of any action involving the subject matter of the foregoing indemnity provision, such indemnified party will, if a claim thereof is to be made
against the indemnifying party pursuant to the provisions of said paragraph (a) or (b), promptly notify the indemnifying party in writing of the commencement thereof; but the omission to so notify the indemnifying party will not relieve it from
any liability which it may have to any indemnified party otherwise than hereunder. In case such action is brought against any indemnified party and it notifies the indemnifying party of the commencement thereof, the indemnifying party shall have the
right to participate in, and, to the extent that it may wish, jointly with any other indemnifying party similarly notified, to assume the defense thereof, with counsel satisfactory to such indemnified party; provided, however, that if the defendants
in any action include both the indemnified party and the indemnifying party and there is a conflict of interest which would prevent counsel for the indemnifying party fiom also representing the indemnified party, the indemnified party or parties
shall have the right to select separate counsel to participate in the defense of such action on behalf of such indemnified party or parties; provided, that the Company’s obligation under Section 9(a) to reimburse any such indemnified party
or parties for legal costs and expenses shall be limited to the legal costs and 

 
expenses of one (1) such separate counsel. After notice from the indemnifying party to such (indemnified party of its election not to assume the defense
thereof, the indemnifying party will not be liable to such indemnified party pursuant to the provisions of said paragraph (a) or (b) for any legal or other expense subsequently incurred by such indemnified party in connection with the
defense thereof other than reasonable costs of investigation, unless (i) the indemnified party shall have employed counsel in accordance with the proviso of the preceding sentence, (ii) the indemnifying party shall not have employed
counsel satisfactory to the indemnified party to represent the indemnified party within a reasonable time after the notice of the commencement of the action or (iii) the indemnifymg party has authorized the employment of counsel for the
indemnified party at the expense of the indemnifymg party. 
 (d) Contribution. If for any reason the indemnification provided
for in paragraphs (a) and (b) is unavailable to an indemnified party or insufficient to hold it harmless as contemplated by such paragraphs, then the indernnifymg party shall contribute to the amount paid or payable by the indemnified
party as a result of such loss, claim, damage or liability in such proportion as is appropriate to reflect not only the relative benefits received by the indemnified party and the indemnifying party, but also the relative fault of the indemnified
party and the indemnifying party, as well as any other relevant equitable considerations; provided, however, that, in any such case, (i) no holder of Common Shares will be required to contribute any amount in excess of the net sales price of
all such Common Shares sold by such holder pursuant to such registration statement and (ii) no holder of Common Shares guilty of a fraudulent misrepresentation (within the meaning of Section ll(f) of the 1933 Act) will be entitled to
contribution from any holder of Common Shares who was not guilty of such fraudulent misrepresentation. 
 Promptly after receipt by a holder
of Common Shares of notice of the commencement of any action, suit or proceeding in connection with a public offering of Common Shares, such holder will, if a claim for contribution in respect thereof is able to be made against another party, notify
the contributing party of the commencement thereof. The omission so to notify the contributing party will not relieve it from any liability which it may have to any other party other than for contribution under the 1933 Act. In case any such action,
suit or proceeding is brought against any party, and such party notifies a contributing party of the commencement thereof, the contributing party will be entitled to participate therein with the notifying party and any other contributing party
similarly notified. 
 10. Transfer of Registration Rights. The registration rights and related obligations provided herein may
be assigned by any Investor to any person or entity that acquires Common Shares from such Investor in accordance with the Second Amended and Restated Shareholders Agreement dated as of the date hereof among the Company and certain of its
stockholders (the “Shareholders Agreement”), and the term “Investor” shall include the original Investor and any person or entity that acquires Common Shares from such Investor or any other Investor; provided, however, that
(a) the Company shall be given written notice by the transferor thereof within a reasonable time after such transfer stating the name and address of the transferee and identifying the securities with regard to which such rights are being
transferred, (b) the transferee shall agree in writing to be bound by this Agreement and to assume the obligations of the transferor hereunder and (c) the registration rights and related obligations may not be transferred with any Common
Shares sold in a registered offering. 

 11. Investors to Provide Information. In the event the Investors request a registration of
Common Shares, the Investors shall provide all such information and materials and shall take all such actions as may be reasonably required in order to permit the Company to comply with all applicable requirements of the SEC and to obtain any
desired acceleration of the effective date of such registration statement. Specifically, the Company may require the Investors to furnish the Company with such information regarding the Investors and the distribution of its securities as the Company
may from time to time reasonably request in writing and as shall be required by law or the SEC. 
 12. Rule 144 Reporting. With
a view to making available the benefits of certain rules and regulations of the SEC which may permit the sale of the Common Shares to the public without registration, the Company agrees to: 
 (a) Make and keep public information available, as those terms are understood and defined in Rule 144 under the 1933 Act, at all times from and after
ninety (90) days following the effective date of the first registration statement under the 1933 Act filed by the Company for an offering of its securities to the general public; 
 (b) Use its best efforts to file with the SEC in a timely manner all reports and other documents required of the Company under the 1933 Act and the
Securities Exchange Act of 1934 (the “1934 Act”); and 
 (c) So long as an Investor owns any Common Shares, furnish to the Investor
forthwith upon request a written statement by the Company as to its compliance with the reporting requirements of the 1933 Act and the 1934 Act, a copy of the most recent annual or quarterly report of the Company and such other reports and documents
so filed as an Investor may reasonably request in availing itself of any rule or regulation of the SEC allowing an Investor to sell any such securities without registration. 
 13. Granting of Registration Rights. The Company shall not, without the prior written consent of Investors holding more than sixty-six and
two-thirds percent (66-213%) of the Common Shares then held by all of the Investors, grant to any person or entity registration rights of any kind or nature with respect to Common Shares or other capital shares of the Company if such rights would
have priority with or priority over the rights granted to the Investors pursuant to this Agreement, whether in terms of the number of shares which holders may include in any registration, the timing of any registration of shares, the rights of
holders to demand registration of shares held by them at the time requested by them or in any other material respect. 
 14.
“Market Stand-Off” Agreement. In connection with the Initial Offering, without the prior written consent of the managing underwriter, during the period commencing on the date of the final prospectus of the Initial Offering and
ending on the date specified by the Company and managing underwriter (such period not to exceed one hundred eighty (180) days), the Investors shall not (A) lend, offer, pledge, sell, contract to sell, sell any option or contract to
purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any Common Shares or any securities convertible into or exercisable or exchangeable for
Common Shares held immediately prior to the effective date of the registration statement for such offering, or (B) enter into any swap or 

 
other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Common Shares, whether any such
transaction described in clause (A) or (B) above is to be settled by delivery of Common Shares or other securities, in cash or otherwise; provided, however, that (i) the foregoing provisions of this Section 14 shall not apply to
the sale of any shares to an underwriter pursuant to an underwriting agreement, and (ii) shall only be applicable to the Investors if all of the Company’s officers, directors and holders of at least half of one percent (0.5%) of the
Company’s then outstanding securities enter into similar agreements. The underwriters in connection with the Company’s Initial Offering are intended third-party beneficiaries of this Section 14 and shall have the right, power and
authority to enforce the provisions hereof as though they were a party hereto. Each Investor further agrees to execute such agreements as may be reasonably requested by the underwriters in the Company’s Initial Offering that are consistent with
this Section 14 or that are necessary to give further effect thereto. Any discretionary waiver or termination of the restrictions of any or all of such agreements by the Company or the underwriters shall apply to all Investors subject to such
agreements pro rata based on the number of shares subject to such agreements. Each Investor agrees that any certificates representing Common Shares shall bear a legend to the effect that such shares are subject to the restrictions imposed by this
Section 14. In order to enforce the foregoing covenant, the Company may impose stop-transfer instructions with respect to the shares (or securities) subject to the foregoing restriction until the end of such period. The Company agrees to use
its best efforts to ensure that all shares of its capital stock (upon issuance after the date hereof) shall be subject to market standoff provisions at least as restrictive as those set forth above. 
 15. Remedies. The Company recognizes and agrees that if the Company fails to comply with its obligations under this Agreement, the Investors may
not have an adequate remedy at law. Such failure will cause the Investors irreparable harm for which there may be no adequate remedy at law, and the Company hereby consents to the issuance of an injunction in favor of the Investors by any court of
competent jurisdiction. The right of such Investors to obtain an injunction hereunder shall not be considered a waiver of any right on the part of the Investors to recover damages and to assert any other claims for remedies which the Investors may
have at law or in equity. The Company agrees to bear any expenses incurred by the Investors, including reasonable attorneys’ fees, in enforcing their rights under this Agreement except in cases in which it is determined that the Company was not
in breach of its obligation to provide such rights. 
 16. Miscellaneous. 
 (a) Waivers and Amendments. This Agreement may be amended or modified in whole or in part only by a writing which makes reference to this
Agreement executed by the Company and Investors (as provided in Section 16(i)). The obligations of any party hereunder may be waived (either generally or in a particular instance and either retroactively or prospectively) only with the written
consent of the party claimed to have given the waiver; provided, however, that any waiver by any party of any violation of, breach of or default under any provision of this Agreement or any other agreement provided for herein shall not be construed
as, or constitute, a continuing waiver of such provision, or waiver of any other violation of, breach of or default under any other provision of this Agreement or any other agreement provided for herein. Notwithstanding the foregoing, any amendment
or waiver which adversely affects any Investor in a manner different than all other Investors shall also require the written approval of such Investor. 

 (b) Entire Agreement. This Agreement sets forth the entire understanding of the parties
hereto and supersedes all prior contracts, agreements, arrangements, communications, discussions, representations and warranties, whether oral or written, among the parties with respect to the subject matter hereof. 
 (c) Governing Law. This Agreement shall in all respects be governed by and construed in accordance with the internal substantive laws of
the State of California without giving effect to the principles of conflicts of law thereof. 
 (d) Notices. Any notice,
request or other communication required or permitted hereunder shall be in writing and be deemed to have been duly given if personally delivered or five (5) business days after being sent by registered or certified mail, return receipt
requested, postage prepaid, to the parties at their respective addresses set forth below. 
  

			
	If to the Company:	 	 Inpatient Consultants Management, Inc.
 4605
Lankershim Boulevard, Suite 617
 North Hollywood, California 91602
 Fax: (818) 766-9781

		
	with a copy to:	 	 Shaw Pittman LLP
 2029 Century Park East, Suite
2550
 Los Angeles, California 90067
 Attention: John J. Molloy
111, Esq.
 Fax: (310) 551-4501

		
	If to MVP:	 	 Morgenthaler Ventures
 629 Euclid Avenue, Suite
700
 Cleveland, Ohio 441 14
 Attention: Keith Kerman

Fax: (216) 621-2817

		
	If to Bessemer:	 	 Bessemer Venture Partners IV L.P.
 Bessemer Venture
Investors L.P.
 Bessec Ventures IV L.P.
 1865 Palmer Avenue,
Suite 104
 Larchmont, NY 10538
 Attention: J. Edmund Colloton

		
	with a copy to:	 	 Bessemer Securities Corp.
 630 Fifth Avenue
 New York, NY 101 11
 Attention: Steven Williamson, Esq.

  

			
	If to BA	 	 Bank of America Ventures
 BA Venture Partners
V
 950 Tower Lane, Suite 700
 Foster City, California
94404
 Attention: Mark Brooks
 Fax: (650)
378-6040

		
	with a copy to:	 	 Cooley Godward LLP
 One Freedom Square
 Reston Town Center
 1 195 1 Freedom Drive
 Reston, VA 20190-5656
 Attention: Ryan E. Naftulin, Esq.
 Fax: (703) 456-8100

		
	If to Crucible:	 	 Crucible Group LLC
 120 Bulkley Avenue, Suite
405
 Sausalito, CA 94965
 Attention: David
Holbrooke

		
	If to CB:	 	 CB Health Ventures, LLC
 800 Boylston Street, Suite 800

 Boston, MA 02199
 Attention: Frederick R.
Blume

		
	If to Piper:	 	 U.S. Bancorp Piper JaEay Inc.
 222 South Ninth Street,
13th Floor
 Minneapolis, MN 55402

		
	If to NSE:	 	 C/O Shaw Pittman LLP
 2029 Century Park East, Suite 2550

 Los Angeles, CA 90067
 Attention: Eric Klein,
Esq.

 Any party by written notice to the others may change the address of the persons to whom notices or
copies thereof shall be directed. 
 (e) Counterparts. This Agreement may be executed in any number of counterparts, each of
which shall be deemed to be an original, and all of which together will constitute one and the same instrument. 
 (f) Successors and
Assigns. This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and assigns, except that the Company may not assign or transfer its rights hereunder without the prior written
consent of each of the Investors. Subject to Section 10 above, each of the Investors shall be entitled to assign all of its rights, benefits and obligations hereunder to any person or entity that acquires Preferred Shares (as hereinafter
defined) or Common Shares from such Investor, without the prior consent of any party and such person or entity shall become an Investor and be entitled to all rights and benefits of an Investor hereunder. 

 (g) Aggregation of Stock. All shares of capital stock held or acquired by affiliated
entities (including prior, successor and affiliated venture capital funds) or persons or entities or persons under common management shall be aggregated together for the purpose of determining the availability of any rights under this Agreement.

 (h) Definition of Common Shares. For the purposes of this Agreement, the term “Common Shares” shall mean
(i) the shares of Common Stock of the Company, $0.001 par value (the “Common Stock”), (ii) any shares of Common Stock issuable upon conversion of outstanding shares of the Company’s Preferred Stock, $0.001 par value, now
designated as Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock (the “Preferred Shares”) may at such time be converted, and
(iii) any shares of Common Stock issuable upon conversion of the Preferred Stock issuable upon exercise of the Warrants. For the purposes of this Agreement, an Investor shall be deemed to be the holder of any shares of Common Stock into which
any Preferred Shares it holds are convertible. 
 (i) Action of the Investors. Wherever this Agreement requires or otherwise
provides for the approval, consent or action of the Investors, such approval, consent or action shall be made in accordance with Section 7.1 of the Shareholders Agreement, as amended from time to time. 
 (j) Founder Shareholders. The “Founder Shareholders” shall mean Adam Singer, M.D., Steven Taback, M.D., James Roach, M.D. and
Robert Singer. The number of shares held of record by each Founder Shareholder is set forth opposite his name on such signature page. 
 (k) Amendment of Prior Agreement. The Registration Rights Agreement is hereby
amended and superseded in its entirety and restated herein. Such amendment and restatement is effective upon the execution of this Agreement by the Company, the holders of at least sixty-six and two-thirds percent (66 2/3%) of the Company’s Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C
Convertible Preferred Stock, voting together as a single class, and holders of at least fifty-one percent (51%) of the Common Shares held by Founder Shareholders outstanding as of the date of this Agreement. Upon such execution, all provisions
of, rights granted and covenants made in the Registration Rights Agreement are hereby waived, released and superseded in their entirety and shall have no further force or effect. 
 [SIGNATURE PAGES FOLLOW] 

 IN WITNESS WHEREOF, the undersigned have executed, or have caused their duly authorized representatives to
execute, this Agreement. 
  

			
	INPATIENT CONSULTANTS MANAGEMENT, INC.
		
	By:	 	 /s/ Adam Singer, M.D.

	Name:	 	Adam Singer, M.D.
	Title:	 	Chief Executive Officer
	
	BANK OF AMERICA VENTURES
		
	By:	 	 /s/ Mark Brooks

	Name:	 	Mark Brooks
	Title:	 	Principal
	
	BA VENTURE PARTNERS V
		
	By:	 	 /s/ Mark Brooks

	Name:	 	Mark Brooks
	Title:	 	General Partner
	
	 CB HEALTHCARE FUND, L.P.,
 a Delaware
limited partnership

		
	By:	 	CB Health Ventures, L.L.C.
	Its:	 	General Partner
	By:	 	 /s/ Frederick R. Blume

	Name:	 	Frederick R. Blume
	Title:	 	Manager
	
	MORGENTHALER PARTNERS VII, L.P.
		
	By:	 	 Morgenthaler Management Partners VII, LLC,
 its Managing
Partner

	By:	 	 /s/ Theodore A. Laufik

	Name:	 	Theodore A. Laufik
	Title:	 	 Chief Financial Officer and
 Managing
Member

  

 IN WITNESS WHEREOF, the undersigned have executed, or have caused their duly authorized representatives to
execute, this Agreement. 
  

			
	MORGENTHALER VENTURE PARTNERS IV, L.P.
		
	By:	 	Morgenthaler Management Partners IV, L.P.,
		 	its Managing Partner
	By:	 	 /s/ Theodore A. Laufik

	Name:	 	Theodore A. Laufik
	Title:	 	 Chief Financial Officer and
 Managing
Member

	
	BESSEMER VENTURE PARTNERS IV L.P.
		
	By:	 	Deer IV & Co., LLC,
		 	its General Partnermanaging Member
	By:	 	 /s/ Edmund Colloton

	Name:	 	J. Edmund Colloton
	Title:	 	Manager
	
	BESSEC VENTURES IV L.P.
		
	By:	 	Deer IV & Co., LLC,
		 	its General Partnermanaging Member
	By:	 	 /s/ Edmund Colloton

	Name:	 	J. Edmund Colloton
	Title:	 	Manager
	
	BESSEMER VENTURE INVESTORS L.P.
		
	By:	 	Deer IV & Co., LLC,
		 	its General Partnermanaging Member
	By:	 	 /s/ Edmund Colloton

	Name:	 	J. Edmund Colloton
	Title:	 	Manager
	
	CRUCIBLE PARTNERS L.P. I
		
	By:	 	The Crucible Group, L.L.C.,
		 	its General Partner
	By:	 	 /s/ David R. Holbrooke

	Name:	 	David R. Holbrooke
	Title:	 	Managing Member

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00135-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00135-of-00352.parquet"}]]